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Abstract 
Purpose: This study is aimed to determine the correlation 
among distress, adherence and quality of life of diabetic 
patients.  
Methods: We used a cross-sectional design. Data were 
collected from diabetec patients at RSUD Abdul Azis 
Singkawang, West Kalimantan, Indonesia, RSUD Meranti 
and RSUD DOK II Jayapura during 2017 and 2018. 
Subjects were patients diagnosed with Type 2 Diabetes 
mellitus (T2DM), aged over 18, and under outpatient 
treatment at the hospitals in the aforementioned period.  
We used Diabetes-Distress Scale (DDS), Morisky 
Medication Adherence Scale-4 (MMAS-4) and EQ-5D to 
measure distress, adherence and quality of life, 
respectively. The Structural Equation Modelling (SEM) 
was used to define the structure of distress, adherence and 
quality of life.  
Results: We recruited 231 patients. The average of blood 
sugars were high (> 150 mg/dl). The four dimensions of 
DDS were moderate (< 3.0), most of the patients were in 
moderate risk of not adherence (55.76%), the index of 
EQ-5D was around 0.7 and the VAS was around 70%. 
The deterioration of quality of life is significantly 
influenced by moderate risk of non- adherence and 
moderated distress. The deterioration of quality of life is 
dominantly influenced by the moderate distress level. The 
moderate risk of non-adherence  is correlated with 
moderate distress.  
Conclusion: Patients’ distress has significant correlation 
with adherence. Distress and adherence have significant 
correlation with quality of life. The moderate risk of non-
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adherence of diabetic patients can cause the worse of 
clinical data, whereas can be the risk of diabetic 
complications. The psychological intervention can push 
the patients to cope with the disease and disease treatment. 
Keywords: distress, adherence, QoL, diabetes, Indonesia. 
1. Introduction 
The prevalence of Type 2 Diabetes mellitus (T2DM) in 
the world has markedly increased. It is estimated that in 
2030 the number of T2DM sufferers in Indonesia will 
reach 21.3 million 1. Basic Health Research reported that 
the highest T2DM prevalence occurred in the provinces of 
Riau (1.0 %), West Kalimantan (0.8 %) and Papua (0.8%) 
1. Diabetes is a chronic disease which can affect patients’ 
quality of life. Health-related quality of life is defines as 
the multidimensional perspective of patients toward the 
current condition. The dimensions measure in the 
perspective of health-related quality of life are physical, 
psychological, social, cognitive and spiritual 2. Health-
related quality of life is one of the treatment’s outcome 
which reflected the quality of health services. Quality of 
life is also associated with the quality of pharmaceutical 
care 3,4. Currently, the number of research about quality of 
life in chronic disease is getting increase. Most of the 
research also made association between predictors of other 
treatment outcome and quality of life 5.  
Some predictors of Health-related quality of life were age, 
duration of disease, number of drug prescribed, 
medication adherence and treatment satisfactory. 
Medication adherence is significantly associated with 
health-related quality of life. The increase of adherence 
can improve the quality of life. In T2DM patients, their 
quality of life significantly related to medication 
adherence 3. The low adherence  of T2DM patients was 
mainly due to the complexity of medicine regimens 5. 
However, previous studies also mentioned that the 
adherence is not related to the health-related quality of life 
6. The contradictive reports could be due to the sample 
size, population characteristics, the adherence method and 
the instruments that used in the study 7.  
The adherence T2DM patients in developed countries are 
low 8–11. Many factors can be contributed in this issue, 
such as; lower literacy, education and counselling session 
in the health care centers. Education level of the patients 
also became the barrier of communication between the 
patients and health care professionals 5. 
The T2DM patients also experienced emotional distress 
due to the limited physical activities, physician –
relationship, interindividual-relationship and long term of 
treatment. Previous studies mentioned that 40% T2DM 
patients experienced depression and T2DM patients had 2-
4 fold greater risk of depression compared to individual 
without T2DM 12–14. Some patients’ characteristics can 
predict the depression as the comorbidity such as; older 
patients, female sex, insulin treatment and the number of 
complication 15. 
According to the high prevalence of T2DM in Indonesia, 
the objectives of this study were to assess the distress 
scale, medication adherence and Health-related quality of 
life and to define the correlations among the scales. We 
plan to explore the distress, adherence and quality of life 
in T2DM patients using validated instruments in Bahasa 
Indonesian versions.  
2. Methods 
2.1. Participants 
We used a cross-sectional design. Data were collected 
from diabetes patients at RSUD Abdul Azis Singkawang, 
West Kalimantan, Indonesia, RSUD Meranti and RSUD 
DOK II Jayapura during 2017 and 2018. The target 
population was diabetes patients receiving outpatient 
services at the hospitals. Subjects who met the inclusion 
criteria were patients diagnosed with T2DM, aged over 18, 
and under outpatient treatment at the hospitals in the 
aforementioned period, whereas the ones excluded were 
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patients who were unwilling to participate in this study and 
those who were illiterate.  
Prior to gathering data from every subject, they were asked 
for their willingness to partake in this research and to 
provide informed consent. The blood sampling was done 
after filling the questionnaires. Data collection resumes 
only if the patient complies. To facilitate data collection 
through questionnaires, the researchers accompanied the 
patients in answering the questions. This study has 
received approval from the Ethics Committee of the 
Faculty of Pharmacy at Universitas Ahmad Dahlan 
Yogyakarta, Indonesia, Number 011701003. 
2.2. Questionnaires 
The questionnaires utilized in this inquiry was the 
Indonesian version of Diabetes-Distress Scale (DDS) 16. 
Polonsky et al. introduced the DDS on patients with type 1 
and T2D at various settings. Patients were asked to express 
their concern about for 1 month on a Likert scale from 1 
(not a problem) to 6 (a very serious problem). This 
questionnaire has four domains, which are; emotional 
burden, physician-related distress, regimen-related distress 
and diabetes-related inter-individual distress 17. The 
distress scales were cathegorized into moderate (>2) and 
high (>3) 18. Adherence was measured by Morisky 
Medication Adherence Scale which contains of four scale 
19. The adherence scales were cathegorized into i) 
adherent, for subjects who answered ‘no’ to all questions, 
ii) moderate risk of adherence for subjects who answered 
‘yes’ in questions number 1 or 2 or in questions number 3 
or 4, and iii) high risk of adherence for subjects who 
answer ‘yes’ in all questions 20. The quality of life was 
measured by Indonesian version of EQ5D, which 
interpreted into index of quality of life and also additional 
measurement of Visual Analog Scale 21. All the 
questionnaires are available in Bahasa Indonesia and 
fulfilled the reliability and validity criteria. 
2.3. Statistical Analysis 
We analyzed the data using SmartPLS v.3 software. The 
Structural Equation Modelling (SEM) was running by 
SmartPLS v.3. The inner model was defined to evaluate 
the endogenous factors. Some of tests such as: 
discriminant validity, convergent validity and reliability 
were evaluated as endogenous factors. The path coefficient 
was determined to evaluate the exogenous model as the 
structural relationship , which can be seen from the 
standardized coefficient and significance. 
3. Results and Discussion 
We recruited  231 patients with 59% among them were 
male. Table 1 shows the T2DM patients’ characteristics. 
According to the education, occupation, salary, marriage 
status, family history, most of the patients are high 
educated, good salary, having family and without family 
history of diabetic. The patients can survive with 
monotherapy for less than 5 years of diabetes and the 
treatment. The average of blood sugars measurements were 
high (> 150 mg/dl). The four dimensions of Diabetes 
Distress Scale were moderate (< 3.0),  most of the patients 
were in the moderate risk of non adherence (55.76%), the 
index of EQ-5D was around 0.7 and the VAS was around 
70%. The quality of life was deteriorate because the value 
of Indonesian health population is 0.921 22.  
In general, the diabetic patients in this study mostly have 
high of blood glucose, which can be seen from the clinical 
data such as; random blood glucose, fasting blood glucose, 
2 hours-post prandial blood glucose and HbA1C. The 
average of disease duration of the patients is less than 5 
years, in fact most of them are treated by metformin. 
Combining with the distress, adherence and quality of life, 
we can see that the patients experienced moderate distress, 
moderate-risk of non- adherence and the deterioration of 
quality of life value. Similar results are found in some 
previous studies, he previous study conducted in US with 
139 diabetic patients, also had similar results that patients 
with uncontrolled T2DM also had depressive symptoms 
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and moderate distress 23. Diabetic patients in Malaysia 
also experienced moderate distress and had negative 
correlation with quality of life. However, the religiousity 
had positive impact to the quality of life 24. Furthermore, 
in United States population, diabetic patients was related 
with serious psychological distress and could diminish the 
quality of life 25.  
According to the value of clinical data, the health 
professionals should be focused on this situation, because 
the treatment outcome has not been reached yet and most 
of the patients experienced macrovascular complications. 
The treatment change or treatment modification should be 
considered to get the normal treatment outcome. The 
combination of metformin with linagliptine or 
sulfonylurea in uncontrolled diabetic patients can be used 
as the treatment choices 26,27.  
Tabel 1. Patients’ characteristics and description of DDS, 
Adherence and QoL (n=231) 
Characteristics N (%) Mean ± SD 
Age   57.14 ±  9.4 
Sex 
Female 
Male 
 
95 (41.12) 
136 (58.88) 
 
 
Education 
Under Senior High School 
Above  Senior High School 
 
 
87 (37.66) 
13 (62.34) 
 
Occupation 
Jobless 
Work 
 
97 (41.99) 
134 (58.01) 
 
Salary (IDR) 
< 2.200.000  
≥ 2.200.000 
 
103 (44.59) 
128 (55.41) 
 
Marriage Status 
Married 
Single 
 
213 (92.2%) 
18 (7.8%) 
 
Family History of DM 
Yes 
None 
 
98 (42.42%) 
133 (57.58%) 
 
Type of medication 
Monotherapy 
Combination therapy 
 
201 (87.01%) 
30 (12.99%) 
 
Duration of Drug used (year) 
< 5  
≥ 5  
 
143 (61.90%) 
88 (38.1%) 
 
1.43 ± 0.59 
 
Duration of DM (year) 
< 5  
≥ 5  
 
121 (52.38%) 
110 (47.62%) 
 
1.47 ± 0.50 
 
Complication 
Microvascular 
Macrovascular 
Microcascular and 
microvascular  
None 
 
60 (25.97%) 
132 (57.14%) 
38 (16.45%) 
1 (0.43%) 
 
Fasting Blood Glucose 
(mg/dl) 
<200 
≥200 
 
117 (50.64%) 
114 (49.36%) 
 
184.60  ± 80.43 
 
 
Random Blood Glucose 
(mg/dl) 
<200 
≥200 
 
 
109 (47.19%) 
122 (52.81%) 
 
 
219.64 ±  85.11 
 
2 hours pp Blood Glucose 
(mg/dl) 
<200 
≥200 
 
 
67 (29.00%) 
164 (70.99%) 
 
 
271.23 ±  22.7 
 
 
HbA1C (%) 
4.4-6.4 
6.4-7.4 
>=7.5 
 
 
37 (16.01%) 
35 (15.15%) 
159 (68.84%) 
 
 
8.68  ±  2.58 
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DDS (moderate) 
Emotional-related distress 
Physician-related distress 
Management-related distress 
Interindividual-related 
distress 
  
2.31 ±   1.28 
2.35 ±  1.27 
2.55 ±  1.08 
2.07 ±  1.25 
Adherence 
Adherent 
Moderate risk of non 
adherence 
High risk of non adherence 
 
58 (26.73%) 
121 (55.76%) 
38 (17.51%) 
 
VAS  71.45 ±  14.44 
Index of EQ5D  0.78 ± 0.25 
Patients had moderate distress in the scale of emotional, 
physician, management and interi-individual. These 
distresses should be treated by some psychological 
intervention then it could be increase the patient’s 
adherence. Previous study mentioned that cognitive and/or 
behavioural intervention for 12 months showed more 
effective outcomes 23. A systematic review with 30 
randomized controlled trials and 9177 subjects concluded 
that some evidences showed the effective treatment 
outcome after psychological interventions 31. Still in 
Malaysian study, medication adherence positive 
correlation with quality of life, meaning that an 
intervention to adherence could improve quality of life 32. 
Continuously, the high adherence will increase the 
patients’ quality of life, because the positive correlation 
between distress-adherence and adherence-quality of life. 
Table 2 shows the results of  SEM about the convergent 
validity of all indicators. All indicators met the criteria of 
convergent validity with the  p value>0.5. 
Table 2. Convergen validity (>0.5) 
  Adherence Distress QoL 
DD1   0,760   
DD2   0,678   
DD3   0,734   
DD4   0,758   
E1     0,737 
E2     0,547 
E3     0,743 
E4     0,728 
E5     0,727 
p-1 0,676     
p-2 0,806     
p-3 0,564     
p-4 0,655     
 
According to the discriminant validity, it can be seen that 
all the indicators were highly correlated with their own 
latent variables (Table 3). Table 4 shows the results of 
reliability test based on Cronbach alpha, composite 
reliability and Average Variance Extracted (AVE). All the 
latent variables met the criteria for the three reliability 
parameters, except for the adherence which did not meet 
the AVE criteria (>0.5). 
Table 3. Discriminant validity 
  Adherence Distress Index QoL VAS 
DD1 0,316 0,760 0,041 0,322 -0,055 
DD2 0,297 0,678 0,213 0,067 0,163 
DD3 0,317 0,734 0,021 0,196 0,051 
DD4 0,275 0,758 0,106 0,277 -0,055 
E1 0,104 0,205 
-
0,073 
0,737 -0,443 
E2 -0,052 0,046 
-
0,032 
0,547 -0,312 
E3 0,059 0,143 0,013 0,743 -0,399 
E4 0,044 0,155 0,210 0,728 -0,355 
E5 0,173 0,322 0,305 0,727 -0,189 
IND 0,087 0,122 1,000 0,186 0,043 
VAS 0,140 0,023 0,043 - 1,000 
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0,441 
p-1 0,676 0,182 0,088 0,113 0,081 
p-2 0,806 0,328 0,101 0,213 0,152 
p-3 0,564 0,170 0,010 
-
0,045 
0,107 
p-4 0,655 0,227 0,074 
-
0,021 
0,161 
Bold number: meet the discriminant validity 
Table 4 Reliability based on Cronbach alpha, Composite 
Reliability and Average Variance Extracted (AVE) 
  
Cronbach's 
Alpha 
Composite 
Reliability 
Average 
Variance 
Extracted 
(AVE) 
Adherence 0,700 0,801 0,302 
Distress 0,715 0,823 0,538 
QoL 0,776 0,826 0,50 
The inner model analysis resulted the R square as can be 
seen in Table 5. The R square value is the determinat of 
endogenous construct. The R square of this model is weak 
because the value is less than 0.19. Distress can explained 
the adherence as much as 11%. Index is inflenced by 
distress through adherence as much as 1.9% and index is 
directly influenced by distress as much as 11%. QoL is 
influenced by distress thourgh index as much as 9.6%. 
VAS is influenced by distress through adherence, index 
and QoL as much as 3.3%.  
Table 5. R Square of endogenous constract 
  R Square 
adherence 0,110 
index 0,019 
qol 0,096 
vas 0,033 
This model is valid and reliable, because the results of 
outer model shows that the models meet the criteria for 
discriminant validity, convergent validity and the 
reliability based on Cronbach alpha, composite reliability 
and AVE.  
Table 6 shows the path coefficients of distress, adherence 
and QoL model. The significant correlation can be seen 
from the correlation between adherence and vas, distress 
and adherence, distress and QoL. The adherence had 
positive correlation with VAS (β=0.19; p=0.011). The 
distress also has positive correlation with adherence and 
QoL (β=0.33; p=0.000 and β=0.30; p=0.000, 
respectively). In general, the path coefficient shows that 
the higher adherence, the higher quality of life,; the higher 
distress, the higher adherence;  and the higher distress, the 
higher quality of life. 
According to the structured model in Fig 1, the 
deterioration of quality of life is significantly influenced 
by moderate-risk of non-adherence  and moderated 
distress. Even though, the correlation value is weak 
because less than 10%. The deterioration of quality of life 
is dominantly influenced by the moderate distress level. 
The value of distress scale are in the category of moderate 
distress level, so that the value of quality of life is good 
(around 0.7). 
Table 6. Path coefficient of distress, adherence  and QoL 
model 
  
Original 
Sample  
Mean SD  T stat 
P 
Values 
adherence -> 
index 
0,072 0,071 0,078 0,929 0,354 
adherence -> qol 0,028 0,033 0,095 0,296 0,767 
adherence -> vas 0,190 0,194 0,074 2,554 0,011* 
distress -> 
adherence 
0,332 0,339 0,048 6,847 0,000* 
distress -> index 0,120 0,118 0,083 1,450 0,148 
distress -> qol 0,308 0,334 0,071 4,321 0,000* 
distress -> vas 0,021 0,013 0,106 0,197 0,844 
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Index= 0.072 adherence + 0.120 distress; QoL= 0.028 
adherence + 0.308 distress; VAS= 0.190 adherence + 
0.021 distress; Adherence= 0.332 distress 
 
DD (1-4); indicators of distress; p (1-4): indicators of 
adherence; E (1-5): indicators of QoL; VAS: Visual 
Analog Scale; IND: Index of QoL  
Fig 1. Structural Model 
This present study shows the moderate risk of non- 
adherence which is correlated with moderate distress. The 
positive correlation between adherence and distress could 
be explained that the complexity of treatment, disease and 
lifestyle could cause the distress, but it can also increase 
the adherence. Some of the supporting factors like family 
support should be consider as the way to decrease the 
distress. The previous study in Malaysia about distress, 
adherence and quality of life depicted that patients with 
low level of distress had high adherence and quality of 
life. Thus, some intervention which can help the patients 
to cope with the disease and disease treatment may 
decrease the distress 28. The previous studies in Germany 
and Taiwan showed similar results with this present study 
due to the significant correlation between adherence and 
quality of life 29,30 .   
The SEM analysis can be used to understand the 
framework of QoL construct development. One of the 
treatment outcomes for the diabetic patients is to increase 
the patient’s quality of life. Thus, factors that can predict 
the quality of life can be structured by SEM. This study 
has limitation, we did not consider the variability of age, 
sex, treatment and other patients’ characteristics in the 
structured analysis. Also we did not consider the 
differences of cultures in the three area over Indonesia. 
Every cultures has its own habit to overcome distress and 
to cope with the disease. 
4. Conclusion 
Patients’ distress has significant correlation with 
adherence. Continuously, distress and adherence have 
significant correlation with quality of life. The moderate 
risk of non- adherence of diabetic patients can cause 
uncontrolled of clinical data, whereas can be the risk of 
diabetic complications. The psychological intervention 
can push the patients to cope with the disease and disease 
treatment. Furthermore, the distress level will decrease 
and can increase the adherence. Quality of life as one of 
the treatment outcomes can describe whether the treatment 
is effective or not. 
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